Strata Critical Medical, Inc. SRTA
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -24.81M | 40.22M | 46.99M | 41.35M | 40.39M |
| Total Depreciation and Amortization | 16.90M | 11.03M | 8.74M | 6.90M | 4.97M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 33.36M | -80.23M | -89.22M | -88.08M | -90.72M |
| Change in Net Operating Assets | -14.72M | -7.05M | -11.29M | -9.08M | 3.01M |
| Cash from Operations | 10.72M | -36.03M | -44.78M | -48.91M | -42.36M |
| Capital Expenditure | -9.92M | -12.42M | -12.16M | -9.60M | -12.32M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -37.18M | -101.36M | -66.54M | -66.54M | -65.17M |
| Divestitures | -1.86M | -3.10M | -3.10M | -2.81M | -1.24M |
| Other Investing Activities | 61.53M | 118.38M | 155.87M | 148.69M | 134.20M |
| Cash from Investing | 12.57M | 1.51M | 74.07M | 69.75M | 55.46M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 113.00K | 174.00K | 185.00K | 193.00K | 183.00K |
| Repurchase of Common Stock | -10.67M | -8.44M | -5.38M | -9.11M | -11.23M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -355.00K | -338.00K | -329.00K | -- | -- |
| Cash from Financing | -10.91M | -8.60M | -5.53M | -8.91M | -11.04M |
| Foreign Exchange rate Adjustments | 0.00 | -616.00K | -465.00K | -339.00K | -448.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 12.39M | -43.74M | 23.30M | 11.59M | 1.61M |